Progress and future prospect of pyridonecarboxylic acids.
Shimizu
M
M
D001419:Bacteria / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D002264:Carboxylic Acids / Q000494:pharmacology*; D004250:DNA Topoisomerases, Type II / Q000235:genetics; D004352:Drug Resistance, Microbial / Q000235:genetics; D011728:Pyridones / Q000494:pharmacology*; D059005:Topoisomerase II Inhibitors
D002264:Carboxylic Acids; D011728:Pyridones; D059005:Topoisomerase II Inhibitors; D004250:DNA Topoisomerases, Type II